Ensuring compliance through collaboration: managing raw material changes in cell and gene therapy regulatory filings

Kasey Kime, Xiao Peng

20 March 2025

Innovator Insight

Enabling allogeneic cell therapy development: scaling up generation of PSC-derived NK cells

Mark Kennedy, Marcus Bunn

10 March 2025

Innovator Insight

Worth the switch? Enhancing process performance for cell therapy manufacturing with an animal component-free raw material strategy

Phil Morton, Shanya Jiang

03 March 2025

Innovator Insight

Maximizing CAR-T cell yields: scalable solutions with perfusion and stirred-tank bioreactors

J Hengst, Q Rafiq, R Ladi et al

27 February 2025

Innovator Insight

Next-generation risk mitigation in the temperature-controlled supply chain for advanced therapies with ISO 21973 compliance

Edward Grimley, Leanne Kodsmann

04 December 2024

Innovator Insight

Navigating cold chain complexity to enable clinical-to-commercial transition of advanced therapies

Susan Li

26 September 2024

Innovator Insight

Can primary packaging selection help mitigate particulate risks in cell and gene therapy manufacturing?

Sean Werner, Joshua Jendusa, Stuart Curbishley

04 June 2024

Innovator Insight

Trends in innovation for downstream process intensification, product yield, single use closed systems, and gentle ATMP bioprocessing: a KOL panel discussing 2024 insights in gene therapy manufacturing

Rachel Legmann, Andrew D Tustian

07 May 2024

Innovator Insight

Expediting development and manufacturing of advanced therapies: critical starting materials case studies

Andrew Frazer

23 April 2024

Innovator Insight

Strategic raw material selection for cell therapy commercialization

Kasey Kime, Lili Belcastro, Kyle Hondorp

09 January 2024

Innovator Insight

A scalable single-use two-step plasmid purification process

P Guterstam, H Blom, S Aberg et al

01 November 2023

Innovator Insight

Exploring & overcoming the challenges of cell & gene-modified cell therapy CMC

Karen Doucette, Julia Sable, Larry Bellot

18 October 2023

Innovator Insight

Sustainable plasmid DNA strategies, achieving streamlined secure supply to clinic & commercialization

Andrew Frazer, Amanda Weiss

26 April 2023

Innovator Insight

Walking on thin ice: controlled freezing & thawing of pharmaceutical active molecules

Barbara Fischer

14 December 2022

Innovator Insight

Cell & gene therapy orchestration: supply chain management in real-time

Andreas Göbel, Dr Camila Mendes

09 November 2022

Innovator Insight

Optimizing cell proliferation and function for immunotherapy with recombinant growth factors and cytokines

Martin Keough

18 September 2022

Innovator Insight

Optimizing and standardizing the cryopreservation of cellular samples: new data and insights from the UK’s Advanced Therapy Treatment Centres network programme

Sandeep Kumar, Julie Meneghel

18 September 2022

Innovator Insight

Putting the patient first: new modalities of manufacturing for cell therapy though real-time process changes

Ben Wang, Kan Wang, Chelsea White

10 March 2022

Innovator Insight

“This is not a sustainable model.”

Joe DePinto, Robert Richards

21 February 2022

Innovator Insight

Considerations for developing scalable and efficient collection network processes

Lacey Anderson, Sara Butler, Allison Montalvo

11 January 2022

Innovator Insight

Success strategies for cell and gene therapy 3.0

Joe DePinto, Richard Gaeto

14 December 2021

Innovator Insight